eMedicine Specialties > Dermatology > Benign Neoplasms

Warty Dyskeratoma: Follow-up

Author: Molly Hinshaw, MD, Assistant Professor, Department of Dermatology, University of Wisconsin School of Medicine and Public Health
Contributor Information and Disclosures

Updated: Mar 10, 2009

Follow-up

Complications

The only complications associated with warty dyskeratoma are those associated with the minor surgical procedures required for the biopsy or the removal of these benign lesions. Potential postsurgical complications, including infection and bleeding, are possible after any surgical procedure.

Prognosis

No known risk of malignant transformation of warty dyskeratoma is reported. Additionally, recurrence is extremely uncommon.

Patient Education

Patients should be reassured that warty dyskeratoma is benign. While patients with Darier disease have been reported with warty dyskeratoma,9 the diagnosis of warty dyskeratoma does not imply that the patient has Darier disease nor is at risk for transmitting Darier disease to offspring. Isolated warty dyskeratoma is not associated with other systemic diseases and patients with a warty dyskeratoma do not need routine follow-up in dermatology.

Miscellaneous

Medicolegal Pitfalls

The only medicolegal pitfall associated with warty dyskeratoma occurs if a lesion is misdiagnosed as acantholytic squamous cell carcinoma. This can occur because both lesions display an endophytic pattern and both exhibit acantholysis. However, warty dyskeratoma has corp ronds and corp grains that are not typically found in squamous cell carcinoma. Warty dyskeratoma also has no more than a mild cytologic atypia, unlike the consistent and sometimes severe cytologic atypia seen in squamous cell carcinoma. Thus, a correct benign diagnosis is possible if careful attention is paid to the architectural and cytologic characteristics of the lesion.

 


More on Warty Dyskeratoma

Overview: Warty Dyskeratoma
Differential Diagnoses & Workup: Warty Dyskeratoma
Treatment & Medication: Warty Dyskeratoma
Follow-up: Warty Dyskeratoma
Multimedia: Warty Dyskeratoma
References
[ CLOSE WINDOW ]

References

  1. Tuominen H, Sormunen R, Kallioinen M. Non-erythroid spectrin (fodrin) in cutaneous tumours: diminished in cell membranes, increased in the cytoplasm. Br J Dermatol. Oct 1996;135(4):576-80. [Medline].

  2. Kaugars GE, Lieb RJ, Abbey LM. Focal oral warty dyskeratoma. Int J Dermatol. Mar 1984;23(2):123-30. [Medline].

  3. Azuma Y, Matsukawa A. Warty dyskeratoma with multiple lesions. J Dermatol. Jun 1993;20(6):374-7. [Medline].

  4. Duray PH, Merino MJ, Axiotis C. Warty dyskeratoma of the vulva. Int J Gynecol Pathol. 1983;2(3):286-93. [Medline].

  5. Griffiths TW, Hashimoto K, Sharata HH, Ellis CN. Multiple warty dyskeratomas of the scalp. Clin Exp Dermatol. Jul 1997;22(4):189-91. [Medline].

  6. Heymann WR. Warty dyskeratoma appearing in a patient with Darier's disease. Int J Dermatol. Sep 1988;27(7):521-2. [Medline].

  7. Kaddu S, Dong H, Mayer G, Kerl H, Cerroni L. Warty dyskeratoma--"follicular dyskeratoma": analysis of clinicopathologic features of a distinctive follicular adnexal neoplasm. J Am Acad Dermatol. Sep 2002;47(3):423-8. [Medline].

  8. Baran R, Perrin C. Focal subungual warty dyskeratoma. Dermatology. 1997;195(3):278-80. [Medline].

  9. Szymanski FJ. Warty dyskeratoma; a benign cutaneous tumor resembling Darier's disease microscopically. AMA Arch Derm. Apr 1957;75(4):567-72. [Medline].

  10. Brownstein MH. The benign acanthomas. J Cutan Pathol. Jun-Aug 1985;12(3-4):172-88. [Medline].

  11. Harrist TJ, Murphy EF, Mihm MC. Oral warty dyskeartoma. Arch Dermatol. 1980;116:929.

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

warty dyskeratoma, WD, focal acantholytic dyskeratosis, isolated keratosis follicularis, Darier disease, Grover disease

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Molly Hinshaw, MD, Assistant Professor, Department of Dermatology, University of Wisconsin School of Medicine and Public Health
Molly Hinshaw, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Women's Dermatologic Society
Disclosure: Nothing to disclose.

Medical Editor

Timothy McCalmont, MD, Director, UCSF Dermatopathology Service, Professor of Clinical Pathology and Dermatology, Departments of Pathology and Dermatology, University of California at San Francisco
Timothy McCalmont, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Society of Dermatopathology, California Medical Association, College of American Pathologists, and United States and Canadian Academy of Pathology
Disclosure: Apsara Consulting fee Independent contractor

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Rosalie Elenitsas, MD, Herman Beerman Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System
Rosalie Elenitsas, MD is a member of the following medical societies: American Academy of Dermatology and American Society of Dermatopathology
Disclosure: Nothing to disclose.

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.